ID

21397

Descrição

NCT00340080 / VIIV-CNA106030 A phase IV, randomised, multicentre, double-blind, study to evaluate the clinical utility of prospective genetic screening (HLA-B*5701) for susceptibility to abacavir hypersensitivity Assessment: Expanded PGx-Pharmacogenetic Research Medicine: abacavir, Condition: Infection, Human Immunodeficiency Virus, Phase: 4, Clinical Study ID: CNA106030, Sponsor: ViiV

Palavras-chave

  1. 19/04/2017 19/04/2017 -
Transferido a

19 de abril de 2017

DOI

Para um pedido faça login.

Licença

Creative Commons BY-NC 3.0

Comentários do modelo :

Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.

Comentários do grupo de itens para :

Comentários do item para :

Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.

Genetic Screening For HLA-B*5701 in Patients with HIV Expanded PGx-Pharmacogenetic Research NCT00340080

Genetic Screening For HLA-B*5701 Expanded PGx-Pharmacogenetic Research NCT00340080

Expanded PGx-Pharmacogenetic Research
Descrição

Expanded PGx-Pharmacogenetic Research

Alias
UMLS CUI-1
C2347500
UMLS CUI-2
C0008976
Subject Identifier
Descrição

Subject Identifier

Tipo de dados

text

Alias
UMLS CUI [1]
C2348585
Has informed consent been obtained for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
Descrição

informed consent

Tipo de dados

text

Alias
UMLS CUI [1]
C0021430
If Yes, record the date informed consent obtained for Expanded PGx-Pharmacogenetic research on safety/tolerability of HAART
Descrição

date informed consent obtained

Tipo de dados

date

Alias
UMLS CUI [1,1]
C0514044
UMLS CUI [1,2]
C0011008
If No, check 􏰀one reason:
Descrição

reason informed consent not obtained

Tipo de dados

integer

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C1882120
If other reason please specify
Descrição

reason informed consent not obtained

Tipo de dados

text

Alias
UMLS CUI [1,1]
C0392360
UMLS CUI [1,2]
C0021430
UMLS CUI [1,3]
C1882120
Has subject withdrawn consent for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
Descrição

Withdrawal of consent

Tipo de dados

text

Alias
UMLS CUI [1]
C1707492

Similar models

Genetic Screening For HLA-B*5701 Expanded PGx-Pharmacogenetic Research NCT00340080

Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Item Group
Expanded PGx-Pharmacogenetic Research
C2347500 (UMLS CUI-1)
C0008976 (UMLS CUI-2)
Subject Identifier
Item
Subject Identifier
text
C2348585 (UMLS CUI [1])
Item
Has informed consent been obtained for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
text
C0021430 (UMLS CUI [1])
Code List
Has informed consent been obtained for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
CL Item
Yes (Y)
CL Item
No (N)
date informed consent obtained
Item
If Yes, record the date informed consent obtained for Expanded PGx-Pharmacogenetic research on safety/tolerability of HAART
date
C0514044 (UMLS CUI [1,1])
C0011008 (UMLS CUI [1,2])
Item
If No, check 􏰀one reason:
integer
C0392360 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
Code List
If No, check 􏰀one reason:
CL Item
Subject declined (1)
CL Item
Subject not asked by Investigator (2)
CL Item
Other (3)
reason informed consent not obtained
Item
If other reason please specify
text
C0392360 (UMLS CUI [1,1])
C0021430 (UMLS CUI [1,2])
C1882120 (UMLS CUI [1,3])
Item
Has subject withdrawn consent for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
text
C1707492 (UMLS CUI [1])
Code List
Has subject withdrawn consent for expanded PGx-Pharmacogenetic research on safety/tolerability of HAART?
CL Item
Yes (Y)
CL Item
No (N)

Use este formulário para feedback, perguntas e sugestões de aperfeiçoamento.

Campos marcados com * são obrigatórios.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial